Delivery Order SPE2D020D0009-SPE2D321F132C

Award Date 6/16/21
Potential Completion Date 6/21/21
Potential Value $84K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lake Zurich, IL, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract, valued at $62,217.12, is for the delivery of Doxycycline Hydrochloride Injection (10), a critical care pharmaceutical product, to support military medical facilities worldwide. The contract is a firm fixed-price delivery order with no set-aside designation....
This federal contract award, valued at $8,517.82, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract is for the delivery of Doxycycline Hydrochloride Injection, a critical care pharmaceutical product, with a completion date of September 27, 2024. This is a firm fixed-price delivery order contract with no set-aside designation. Fresenius Kabi, LLC is...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract is for the delivery of DOXYCYCLINE HYDROCHLORIDE INJECTION (10), a critical care medication, to military medical facilities worldwide. The contract has a ceiling value of $79,808.27 and is a firm fixed-price, non-set-aside delivery order with a completion date of...
This is a delivery order contract awarded to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company, by the Defense Logistics Agency (DLA) Troop Support Medical division. The contract is for the supply of doxycycline hydrochloride injection (10) at a ceiling value of $3,333.06. The contract has a firm fixed price pricing type and an ultimate completion date of September 27, 2024. This delivery order is not set aside and is part of Fresenius Kabi's broader indefinite delivery...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical division awarded a $1,666.53 firm fixed-price delivery order contract to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract is for the delivery of doxycycline hydrochloride injection, a critical care pharmaceutical product, with a period of performance through September 27, 2024. Fresenius Kabi is a major supplier of injectable medications and medical solutions to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Medical Supply Chain division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The award, valued at $5,369.93, is a delivery order contract for the supply of doxycycline hydrochloride injection (10) to military and federal healthcare facilities. The contract has a period of performance through September 27, 2024 and is structured as a firm fixed-price...
The Defense Logistics Agency Troop Support Medical awarded a $114,161.02 firm fixed-price delivery order to Fresenius Kabi, LLC, a foreign-owned pharmaceutical company, for the provision of doxycycline hydrochloride injection. The order, which did not utilize a set-aside, will be fulfilled from Fresenius Kabi's production facility in Lake Zurich, Illinois, with a completion date of June 18, 2021. This delivery order is likely part of a broader blanket purchase agreement or indefinite delivery...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Fresenius Kabi USA, LLC, a foreign-owned for-profit pharmaceutical company. The contract is for the delivery of 10 units of Doxycycline Hydrochloride Injection, a critical antibiotic medication, with a ceiling value of $83,365.00 and a period of performance ending on November 22, 2017. This award is not designated as a set-aside contract. Fresenius Kabi USA, LLC has been awarded numerous...
This is a definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Fresenius Kabi, LLC, a foreign-owned for-profit pharmaceutical company. The contract, valued at $41,636,277.00, is for the delivery of pharmaceutical and medical supplies, with no set-aside designation. The contract is structured as a firm fixed-price, delivery order arrangement to support medical facilities worldwide, particularly for the Department of Defense...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract, valued at $9,692.20, is a delivery order for the supply of 4,566,185,312 units of Vancomycin 1 gram vials. The contract has an ultimate completion date of October 28, 2024, and is a firm fixed-price contract. Fresenius Kabi, LLC is a significant supplier of critical care...
  • SPE2D020D0009
    Indefinite Delivery Contract
  • SPE2D020D0009-SPE2D321F132C
    Delivery Order

This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract is for the delivery of Doxycycline Hydrochloride Injection, a critical care injectable medication, to federal government agencies, including the Department of Defense and Department of Veterans Affairs. The contract has a ceiling value of $83,854.43 and is structured as a Firm Fixed Price, Delivery Order, with an ultimate completion date of June 21, 2021. Fresenius Kabi, LLC holds a significant Indefinite Delivery Contract (IDC) with the Department of Veterans Affairs National Acquisition Center for the supply of Bortezomib, a cancer treatment drug, valued at $2.24 million over a five-year period. This contract supports pharmaceutical requirements for multiple federal agencies, demonstrating the company's capability to manage large-scale pharmaceutical supply contracts for critical medical treatments across various federal healthcare systems.

Generated 4/2/25, 5:00 PM